Annual Accounts

Neuroendocrine Cancer UK is dedicated to providing support and information to people affected by Neuroendocrine Cancer.

Our work is made possible because of the kindness and generosity of our supporters. Thank you to everyone helping us get one step closer to reaching our vision of a world where people know how to recognise, diagnose, treat, care for and, ultimately, cure patients with Neuroendocrine Cancer.

Accounts finance Circle web (12)

<img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" alt="" title="" srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790" />

DOWNLOAD

NCUK Accounts 2022

Annual report and unaudited financial statements for the year ended 30 September 2022.

<img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" alt="" title="" srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790" />

DOWNLOAD

NCUK Accounts 2021

Annual report and unaudited financial statements for the year ended 30 September 2021.

<img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" alt="" title="" srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790" />

DOWNLOAD

NCUK Accounts 2020

Annual report and unaudited financial statements for the year ended 30 September 2020.

<img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" alt="" title="" srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790" />

DOWNLOAD

NPF Accounts 2019

Annual report and unaudited financial statements for the year ended 30 September 2019.

<img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" alt="" title="" srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790" />

DOWNLOAD

NPF Accounts 2018

Annual report and unaudited financial statements for the year ended 30 September 2018.

<img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" alt="" title="" data-srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" data-src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" data-sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img decoding="async" width="1000" height="900" src="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg" alt="" title="" srcset="https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box.jpg 1000w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-980x882.jpg 980w, https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/05/annual-accounts-box-480x432.jpg 480w" sizes="(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1000px, 100vw" class="wp-image-9790" />

DOWNLOAD

NPF Accounts 2017

Annual report and unaudited financial statements for the year ended 30 September 2017.

Where would you like to visit next?

Select the image to learn more.



Symptoms



Tests



Newly diagnosed



Treatments



Your cancer site



What is Neuroendocrine Cancer?



Living with Neuroendocrine Cancer



How we can support you



NC research and our campaign work



End of life care